|
SDHC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62858615482264E-12 |
| Normal-vs-Stage2 |
2.44599999998929E-06 |
| Normal-vs-Stage3 |
4.93479999974511E-07 |
| Normal-vs-Stage4 |
1.52943999999211E-05 |
| Stage1-vs-Stage2 |
3.972000E-01 |
| Stage1-vs-Stage3 |
1.946190E-01 |
| Stage1-vs-Stage4 |
9.862400E-01 |
| Stage2-vs-Stage3 |
8.258200E-01 |
| Stage2-vs-Stage4 |
5.821800E-01 |
| Stage3-vs-Stage4 |
4.324200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62492241884138E-12 |
| Normal-vs-AfricanAmerican |
1.68990377247269E-11 |
| Normal-vs-Asian |
2.573600E-04 |
| Caucasian-vs-AfricanAmerican |
8.895400E-01 |
| Caucasian-vs-Asian |
4.266200E-01 |
| AfricanAmerican-vs-Asian |
4.237400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.41609945991661E-10 |
| Male-vs-Female |
1.955350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.30779950705085E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.67920019503265E-10 |
| Normal-vs-Extreme_Obese |
1.341550E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.745800E-01 |
| Normal_Weight-vs-Obese |
7.969000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.836600E-01 |
| Extreme_Weight-vs-Obese |
1.571580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.625400E-01 |
| Obese-vs-Extreme_Obese |
4.813800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.2022999979221E-08 |
| Normal-vs-Age(41-60Yrs) |
2.1094237467878E-15 |
| Normal-vs-Age(61-80Yrs) |
2.5113244817021E-13 |
| Normal-vs-Age(81-100Yrs) |
3.93240000007289E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.363000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.127400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.821000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.232400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.006800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.766400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
8.3744000001218E-07 |
| Normal-VS-KIRP CIMP |
2.63889999851941E-08 |
| Normal-VS-Unclassified PRCC |
6.00739458178623E-11 |
| Type1 PRCC-VS-Type2 PRCC |
4.429300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.430000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.032000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.224400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.315820E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.228200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.3228000068396E-09 |
| Normal-vs-N1 |
1.0728999999543E-07 |
| Normal-vs-N2 |
7.785700E-04 |
| N0-vs-N1 |
7.913400E-01 |
| N0-vs-N2 |
5.153600E-01 |
| N1-vs-N2 |
5.735200E-01 |
|
|
